12:11 PM EST - Gemina Laboratories : Announces the successful completion of its human performance study for the Gemina Legio XTM COVID-19 Rapid Antigen test, a significant development milestone demonstrating the power of Gemina's novel patented chemistry. Gemina Laboratories
shares C.GLAB are trading up $0.17 at $0.63.
